A large randomised assessment of the relative cost-effectiveness of different classes of drugs for Parkinson's disease (PD MED)

Gray R, Rick C, Rowland N, Williams A, Gray A, Clarke C, Jenkinson C, Wheatley K
Record ID 32001000791
Project Status: Ongoing
Anticipated Publish Date: 2022
Requestor: NIHR Health Technology Assessment programme
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England, United Kingdom
MeSH Terms
  • Parkinson Disease
  • Cost-Benefit Analysis
  • Drug Therapy
  • Antiparkinson Agents
  • Carbidopa
  • Levodopa
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.